paridiprubart (EB07) - Edesa Biotech, Light Chain Biosci
Gohibic (vilobelimab) - Staidson Biopharma, InflaRx
Avastin (bevacizumab) - Roche
http://clinicaltrials.gov/ct2/show/NCT06703073
 
Nov 26, 2025
 
Next